Scientific publications

JCI Insight, 2025

Icotrokinra induces early and sustained pharmacodynamic responses in phase IIb study of patients with moderate-to-severe psoriasis

Strawn D., Krueger J., Bissonnette R. et al.

Cytokine, 2025

Associations between plasma ANGPTL4 levels and the risk of 24 cancers: a prospective cohort study

Cheng X., Zhao S., Du M. et al.

Hepatology Research, 2025

Plasma Vascular Endothelial Growth Factor‐A Identified by Proximity Extension Assay Predicts Early Progression in Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab

Tajima K., Miuma S., Sasaki R. et al.

Journal of the Endocrine Society, 2025

Urinary Proteomics as a Noninvasive Readout of Obesity-associated Inflammation

Canki E., Kho E., van Stiphout R. et al.

Cancer Immunology, Immunotherapy, 2025

Immunomodulatory effects of lenvatinib in patients with advanced thyroid cancer

Changoer P., Peng C., van Houten P. et al.

Pancreas, 2025

Plasma Proteomics Identifies Potential Pancreatic Cancer Risk Indicators in Type 2 Diabetes

Chu S., Liu J., Liu X. et al.

International Journal of Molecular Sciences, 2025

Development of a High-Throughput Screening Platform and a Pathogenesis Model for Leishmania Infection Based on Mouse Hepatic Organoids

González-Montero M., Andrés-Rodríguez J., Criado M. et al.

Inflammatory Bowel Diseases, 2025

Primary infliximab failure in pediatric colonic inflammatory bowel disease: Development of a proteomics predictive model using a prospective Canadian cohort

Ricciuto A., Turinsky A., Griffiths A. et al.

Circulation, 2025

IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes

Hundertmark M., Birkhoelzer S., Portwood C. et al.

PLOS One, 2025

Lack of association between loneliness, social isolation and inflammation in people living with HIV aged ≥50 years: Results from the sub-study “No One Alone-Gesida Study”

Blanco J., Albendin-Iglesias H., Negredo-Puigmal E. et al.

Inflammatory Bowel Diseases, 2025

Plasma Proteomics for Risk Prediction and Therapeutic Target Discovery in Crohn’s Disease and Ulcerative Colitis

Gan X., Zhang Y., Zhang Y. et al.

BMJ Neurology Open, 2025

Blood biomarkers of seizures in epilepsy: machine learning reveals altered plasma proteome

Akel S., Ashtiani S., Sarangdhar M. et al.

International Journal of Cardiology, 2025

The association between collagen 1a1, NTproBNP and echocardiographic markers in patients with or at risk of HFpEF

Rastogi T., Kobayashi M., Ferreira J. et al.

Medicine, 2025

A two-sample Mendelian randomization analysis of the impact of GABA receptor subtypes on human height

Chen L., Zeng Z., Wu M. et al.

Medicine, 2025

Identification of therapeutic targets for insomnia through genetic and plasma proteomic approaches

Wang X., Lu J., Lin F. et al.

Acta Neuropathologica Communications, 2025

Distinct cerebrospinal fluid proteomic signatures define clinicopathological subtypes of sporadic Creutzfeldt-Jakob disease and predict patient survival

Bentivenga G., Mammana A., Gogishvili D. et al.

Journal of the European Academy of Dermatology and Venereology, 2025

High‐throughput proteomics uncovers molecular clusters and biomarkers of severity in bullous pemphigoid

Calabrese L., Vallini G., Bonacchi L. et al.

The Journal of Pathology: Clinical Research, 2025

Systemic and local decorin levels mirror the clinical course of pancreatic cancer

Svensson M., Lehn S., Jacobsen H. et al.

Cardiovascular Diabetology, 2025

Proteomic signature of metabolic dysfunction-associated steatotic liver disease and risk of atherosclerotic cardiovascular disease

Pan L., Shen M., Liu Y. et al.

Nature Communications, 2025

Complex genetic effects linked to plasma protein abundance in the UK Biobank

Sigurdsson A., Gräf J., Yang Z. et al.